Structure |
Chemical Name |
CAS |
MF |
 |
1-(2,3-DiMethylphenyl)-1-(1H-iMidazol-4-yl)ethanol |
86347-12-8 |
C13H16N2O |
 |
Ropivacaine-iPr-R |
1050482-18-2 |
C17H26N2O |
 |
Demiditraz IMpurity |
944268-66-0 |
C20H22N2O |
 |
AcarBose EP Impurity B |
1220983-54-9 |
C26H43NO17 |
 |
Alogliptin Impurity 17 |
|
|
 |
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
 |
Betamethasone EP Impurity H |
185613-71-2 |
C22H29FO5 |
 |
Blonanserin Impurity 10 |
132810-87-8 |
C23H30ClN3 |
 |
Blonanserin impurity G |
|
|
 |
Cefodizime Impurity 5 |
|
|
 |
Clindamycin Impurity 4 |
|
|
 |
Doxofylline Impurity 4 |
2095554-12-2 |
C11H16N4O5 |
 |
Eltrombopag Impurity 1 |
1246929-02-1 |
C25H23N5O3 |
 |
Everolimus impurity A |
|
|
 |
Fosaprepitant Impurity 13 |
|
|
 |
Gefitinib Impurity J |
|
|
 |
Isavuconazole Impurity 23 |
|
|
 |
Isavuconazole Impurity 29 |
|
|
 |
Isavuconazole Impurity 7 |
|
|
 |
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
 |
Linagliptin Impurity 43 |
|
|
 |
MiraBegron Impurity A |
|
|
 |
Moxifloxacin Impurity 15 |
|
|
 |
Moxifloxacin Impurity 32 |
|
|
 |
Nifedipine Impurity F |
53055-15-5 |
C18H20N2O6 |
 |
Olaparib Impurity 15 |
2250243-17-3 |
C24H25FN4O3 |
 |
Olopatadine Impurity 4 |
55690-15-8 |
C18H18O5 |
 |
Posaconazole Impurity 26 |
|
|
 |
Posaconazole Impurity 48 |
1902954-03-3 |
C37H42F2N8O5 |
 |
Posaconazole Impurity 9 |
|
|
 |
Roxithromycin Impurity E |
|
|
 |
SofosBuvir impurity 48 |
|
|
 |
SofosBuvir Impurity 54 |
1431932-81-8 |
C12H17ClNO4P |
 |
Timolol EP Impurity G |
75202-36-7 |
C6H9N3O3S |
 |
Tofacitinib Impurity 44 |
2374700-39-5 |
C13H19N5 |
 |
Trelagliptin Impurity 24 |
|
|
 |
dimethyl 3- isobutylpentanedioate |
145328-03-6 |
C11H20O4 |
![Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]-](/CAS/20180601/GIF/1408077-50-8.gif) |
Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- |
1408077-50-8 |
C15H15ClO2 |
![2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one](/CAS/20180601/GIF/1984788-96-6.gif) |
2-amino-9-((3aS,4S,6S,6aR)-3a,6-dihydroxyhexahydro-1H-cyclopenta[c]furan-4-yl)-1,9-dihydro-6H-purin-6-one |
1984788-96-6 |
C12H15N5O4 |
 |
Ampicillin Impurity C |
|
|
 |
Ampicillin Impurity O |
|
|
 |
mixture of PD 312236 and PD 312237 |
|
|
 |
Axitinib Impurity 27 |
1639137-80-6 |
C24H20N4O2S |
![(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate](/CAS/20180601/GIF/104873-15-6.gif) |
(4R,5R,6S)-4-nitrobenzyl 6-((R)-1-hydroxyethyl)-4-methyl-3,7-dioxo-1-azabicyclo[3.2.0]heptane-2-carboxylate |
104873-15-6 |
C17H18N2O7 |
 |
Lesinurad Impurity |
|
|
 |
Chrysophanol triglucoside |
120181-07-9 |
C33H40O19 |
![7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-](/CAS/20180601/GIF/1829588-57-9.gif) |
7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-(5-chloro-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl- |
1829588-57-9 |
C17H19ClN4O2 |
 |
Cefminox sodium impurities Ⅲ |
|
|
 |
Canagliflozin Impurity 18 |
1951467-29-0 |
C24H25FO6S |
 |
Fosaprepitant Impurity 6 |
327623-34-7 |
C21H19F6NO3 |
 |
Ivabradine Impurity 16 HCl |
304464-98-0 |
C26H34N2O5 |
 |
Moxifloxacin EP Impurity A HCl |
|
|
 |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
 |
Solifenacin Related Compound 13 |
1251905-45-9 |
C17H17NO2 |
 |
Oxaliplatin impurity |
|
|
 |
NiMesulide EP IMpurity |
38880-53-4 |
C7H8N2O5S |
 |
Alogliptin Impurity D |
1926163-25-8 |
C61H86N16O13 |
 |
Moxifloxacin Impurities |
|
|
 |
Parecoxib Impurity K |
198471-69-1 |
C17H16N2O3S |
 |
Linagliptin Impurity K |
1638744-06-5 |
C25H29BrN8O2 |
 |
(R)-2-((6-(3-((3-(2-cyano-5-fluorobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile |
1917324-13-0 |
C31H28F2N8O4 |
![L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1)](/CAS/20211123/GIF/1194550-65-6.gif) |
L-Phenylalanine, N-[(5,7-dichloro-1,2,3,4-tetrahydro-6-isoquinolinyl)carbonyl]-3-(methylsulfonyl)-, phenylmethyl ester, hydrochloride (1:1) |
1194550-65-6 |
C27H27Cl3N2O5S |
 |
Alogliptin Related Compound 23 |
1618644-29-3 |
C20H13ClN4O2 |
 |
Etoricoxib Impurity 14 |
|
|
 |
Riociguat Impurtiy 3 |
|
|
 |
Trelagliptin Impurity 2 |
|
|
 |
Chlorhexidine Impurity B |
1308292-89-8 |
C16H26ClN9O |
 |
Dapoxetine Impurity D |
|
|
 |
Eltrombopag Impurity 5 |
|
|
 |
Exemestane Impurity 1 |
159354-61-7 |
C20H24O3 |
 |
Iguratimod Impurity 9 |
1179354-65-4 |
C18H16N2O6S |
 |
Lidocaine Impurity |
35891-84-0 |
C11H16N2O.ClH |
 |
Pramipexole Impurity J |
|
|
 |
Solifenacin Related Compound 14 |
605696-10-4 |
C25H30N2O2 |
 |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
![1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide](/CAS/20180703/GIF/503612-76-8.gif) |
1-(4-Hydroxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-76-8 |
C24H23N5O4 |
![8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one](/CAS/20180703/GIF/869478-13-7.gif) |
8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one |
869478-13-7 |
C28H32N2O5 |
![1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/CAS/20180703/GIF/743460-48-2.gif) |
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
743460-48-2 |
C21H27N3O2 |
 |
Cefuroxime Sodium impurity D |
|
C16H16N4NaO8S |
 |
Silodosin impurity A |
|
|
 |
cefditoren △-3 isomer |
|
|
 |
Ixazomib Impurity 1 |
1201903-02-7 |
C24H33BCl2N2O4 |
 |
Ofloxacin/Levofloxacin Impurity E |
|
|
![(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid](/CAS/20180703/GIF/1026952-91-9.gif) |
(3S)-9,10-difluoro-3-methyl-7-oxo-2,3,6,7-tetrahydro-5H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid |
1026952-91-9 |
C13H11F2NO4 |
 |
((4-Methoxyphenoxy)methylene)dibenzene |
85686-16-4 |
C20H18O2 |
 |
Tofacitinib Impurity L |
|
|
 |
1-chloro-3-(dimethoxymethyl)benzene |
3395-80-0 |
C9H11ClO2 |
 |
N-(3-bromo-4-oxocyclohexyl)acetamide |
687639-03-8 |
C8H12BrNO2 |
 |
methyl (Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
C44H51N9O4 |
 |
Alvimopan Impurity 5 |
|
|
 |
Palbociclib-d8 |
1628752-83-9 |
C24H21D8N7O2 |
![1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide](/CAS/20180601/GIF/2101651-50-5.gif) |
1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide |
2101651-50-5 |
C14H12FN5 |
 |
N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide |
152504-12-6 |
C22H31ClN10 |
 |
Ethylmethyl-carbamic chloride |
42252-34-6 |
C4H8ClNO |
![N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide](/CAS/20180601/GIF/329941-39-1.gif) |
N-(3-{[(4-methylphenyl)sulfonyl]amino}phenyl)acetamide |
329941-39-1 |
C15H16N2O3S |
 |
Cisatracurium-20-methyl Dibenzenesulfonate |
1193104-85-6 |
C60H79N2O15S+ |
![[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE](/CAS/GIF/128311-06-8.gif) |
[R-(R*,S*)]-(-)-N-(1-PHENYLETHYL)-1-AZABICYCLO[2.2.2]OCTAN-3-AMINE DIHYDROCHLORIDE |
128311-06-8 |
C15H24Cl2N2 |
 |
GURKHSYORGJETM-MGDILKBHSA-N |
1992961-26-8 |
C33H39ClN4O6 |
 |
DVCUGHHGLKCBMT-QVDQXJPCSA-N |
1356353-76-8 |
C15H24N6O6 |
 |
5,6-Dehydro-Tigecycline |
1633815-62-9 |
C29H37N5O8 |